BACKGROUND & AIMS: One of the central, unresolved issues in the pathogenesis of acute pancreatitis is the uncertainty regarding the mechanisms responsible for the premature intrapancreatic activation of digestive enzyme zymogens. The aim of the current study was to develop and characterize an in vitro system that might mimic the events leading to trypsinogen activation within the pancreas during pancreatitis. METHODS: Activation of trypsinogen in response to stimulation with cerulein was quantitated in isolated rat pancreatic acini. RESULTS: Activation of trypsinogen was detected within 10 minutes of exposing isolated rat pancreatic acini, in Ca2+-containing buffer, to a supramaximally stimulating concentration of cerulein in vitro. Complete inhibition of pancreatic cathepsin B activity with E-64d, a specific, potent and irreversible cathepsin B inhibitor, prevents cerulein-induced in vitro trypsinogen activation. CONCLUSIONS: In vitro activation of trypsinogen can be detected when pancreatic acini are exposed to a supramaximally stimulating dose of cerulein. The results using this in vitro system support the hypothesis that the appearance of active trypsin within the pancreas during the early stages of cerulein-induced pancreatitis reflects activation of trypsinogen by the lysosomal hydrolase cathepsin B.
BACKGROUND & AIMS: One of the central, unresolved issues in the pathogenesis of acute pancreatitis is the uncertainty regarding the mechanisms responsible for the premature intrapancreatic activation of digestive enzyme zymogens. The aim of the current study was to develop and characterize an in vitro system that might mimic the events leading to trypsinogen activation within the pancreas during pancreatitis. METHODS: Activation of trypsinogen in response to stimulation with cerulein was quantitated in isolated ratpancreatic acini. RESULTS: Activation of trypsinogen was detected within 10 minutes of exposing isolated ratpancreatic acini, in Ca2+-containing buffer, to a supramaximally stimulating concentration of cerulein in vitro. Complete inhibition of pancreaticcathepsin B activity with E-64d, a specific, potent and irreversible cathepsin B inhibitor, prevents cerulein-induced in vitro trypsinogen activation. CONCLUSIONS: In vitro activation of trypsinogen can be detected when pancreatic acini are exposed to a supramaximally stimulating dose of cerulein. The results using this in vitro system support the hypothesis that the appearance of active trypsin within the pancreas during the early stages of cerulein-induced pancreatitis reflects activation of trypsinogen by the lysosomal hydrolase cathepsin B.
Authors: V P Singh; A K Saluja; L Bhagat; G J van Acker; A M Song; S P Soltoff; L C Cantley; M L Steer Journal: J Clin Invest Date: 2001-11 Impact factor: 14.808
Authors: W Halangk; M M Lerch; B Brandt-Nedelev; W Roth; M Ruthenbuerger; T Reinheckel; W Domschke; H Lippert; C Peters; J Deussing Journal: J Clin Invest Date: 2000-09 Impact factor: 14.808
Authors: Ana De La Mano; Sara Sevillano; Isabel De Dios; Secundino Vicente; Manuel Antonio Manso Journal: Mol Cell Biochem Date: 2002-11 Impact factor: 3.396
Authors: Matthew C Koopmann; Megan D Baumler; Christopher J Boehler; Faye L Chang; Denise M Ney; Guy E Groblewski Journal: Pancreas Date: 2010-04 Impact factor: 3.327
Authors: Daniel S John; Julia Aschenbach; Burkhard Krüger; Matthias Sendler; F Ulrich Weiss; Julia Mayerle; Markus M Lerch; Ali A Aghdassi Journal: J Biol Chem Date: 2018-11-19 Impact factor: 5.157
Authors: Edwin C Thrower; Sara Osgood; Christine A Shugrue; Thomas R Kolodecik; Anamika M Chaudhuri; Joseph R Reeve; Stephen J Pandol; Fred S Gorelick Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-04-03 Impact factor: 4.052
Authors: Ahmed Bettaieb; Shinichiro Koike; Samah Chahed; Santana Bachaalany; Stephen Griffey; Juan Sastre; Fawaz G Haj Journal: Am J Pathol Date: 2016-07-20 Impact factor: 4.307